The Mark Foundation for Cancer Research Teams Up with Takeda to Fund Groundbreaking Research to Uncover and Target Novel Cancer Vulnerabilities
The Mark Foundation for Cancer Research Announces More Than $2 Million in Funding for Two New Drug Discovery Awards for Pancreatic Cancer and Anticancer Therapeutics | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Awards ~$12 million to Cancer Grand Challenges Team Developing Novel Immunotherapies for Childhood Solid Tumors | The Mark Foundation for Cancer Research
New Blood Discoveries Grant Program Supported by Novel Three-Way Collaboration | The Mark Foundation for Cancer Research
Because Cancer is Not an Island: Progress in the AACR-The Mark Foundation for Cancer Research “Science of the Patient” SOP Grants | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research on X: "#MarkSymposium 2023 closes with Emerging Leader awardee Jaehyuk Choi @jaehyukchoimd @NUFeinbergMed, Momentum Fellow Florian Perner @Florian_Perner @UMGreifswald, and Endeavor awardee Reuben Shaw @LabReuben ...
Blog | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Teams Up with Takeda to Fund Groundbreaking Research to Uncover and Target Novel Cancer Vulnerabilities | The Mark Foundation for Cancer Research
Fellowships | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Teams Up with Takeda to Fund Groundbreaking Research to Uncover and Target Novel Cancer Vulnerabilities | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research and RUNX1 Research Program Announce STRIVE Awardees | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research on LinkedIn: #worldcancerresearchday #cancerresearch
Scientific Symposium 2022 | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Appoints Ryan Schoenfeld as CEO | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Awards ~$12 million to Cancer Grand Challenges Team Developing Novel Immunotherapies for Childhood Solid Tumors | The Mark Foundation for Cancer Research
Endeavor: A Preview | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Partners with the Israel Cancer Research Fund to Support a Project Grant at Weizmann Institute in Israel - Israel Cancer Research Fund
Home | The Mark Foundation for Cancer Research
Inaugural Endeavor Award Recipients Announced | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Appoints Ryan Schoenfeld as CEO | The Mark Foundation for Cancer Research
Events | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Announces 2022 Emerging Leader Awards | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Investor Profile: Portfolio & Exits | PitchBook
The Mark Foundation for Cancer Research Appoints Two New Members to Board of Directors | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Appoints Raymond N. DuBois as Executive Chairman; Announces Founder Alex Knaster's $500 Million New Funding Commitment | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Expands Global Outreach with New ASPIRE Awards | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Appoints Raymond N. DuBois as Executive Chairman; Announces Founder Alex Knaster's $500 Million New Funding Commitment | The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research Expands Partnership with The Johns Hopkins University to Accelerate Groundbreaking Immunotherapy Research | Johns Hopkins Medicine
